The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
1564
January 28, 2019
View Complete Issue         Table of Contents 2019 
OTC Primatene Mist Returns
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
OTC Primatene Mist Returns
January 28, 2019 (Issue: 1564)
The FDA has approved over-the-counter (OTC) sale of inhaled epinephrine (Primatene Mist – Amphastar), a nonselective alpha and beta agonist, for temporary relief of mild symptoms of intermittent asthma in patients ≥12 years old who have been...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App
  • FREE online per issue CME/CE
Purchase this article:
Title: OTC Primatene Mist Returns
Article code: 1564a
 Electronic, downloadable article - $45


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.